The problem is that medullary cancer is so rare and develops so slowly over decades, that there is be no easy way to rule out the possibility that the drugs might boost cancer risk decades after people start taking them.

FORBES: Drug Safety

But the fortunes of the Cup holders have been transformed since that defeat, and Vickery says there is no easy way to win the ultimate prize.

BBC: Boks defeat still hurts - Vickery